Assignee
FERRING INT CENTER SA
CH·10 granted patents·4 pending applications·34 citations·filing 2014–2025
Top patents by PatentIndex Score
14 records- 0193US11952407B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2021·Granted Apr 9, 2024·2 cites·5 claims
- 0293US10995128B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2017·Granted May 4, 2021·7 cites·8 claims
- 0390US9771407B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2016·Granted Sep 26, 2017·8 cites·15 claims
- 0488US9546204B2Recombinant FSH including alpha 2,3- and alpha 2,6-sialylationFERRING INT CENTER SA·Filed 2014·Granted Jan 17, 2017·8 cites·17 claims
- 0587US12516094B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2024·Granted Jan 6, 2026·0 cites·7 claims
- 0682US10624879B2Liquid pharmaceutical compositionFERRING INT CENTER SA·Filed 2017·Granted Apr 21, 2020·4 cites·19 claims
- 0780US11191753B2Liquid pharmaceutical compositionFERRING INT CENTER SA·Filed 2020·Granted Dec 7, 2021·2 cites·21 claims
- 0880US2022323538A1Methods for treating metastatic stage prostate cancerFERRING INT CENTER SA·Filed 2022·Application pending·0 cites
- 0979US10799423B2Liquid-transfer adapter beveled spikeFERRING INT CENTER SA·Filed 2017·Granted Oct 13, 2020·3 cites·21 claims
- 1072US2026015590A1Methods of producing recombinant adenovirus vectorsFERRING INT CENTER SA·Filed 2024·Application pending·0 cites
- 1168US12576072B2Liquid pharmaceutical compositionFERRING INT CENTER SA·Filed 2021·Granted Mar 17, 2026·0 cites·20 claims
- 1253US2025354170A1Method for the manufacture of recombinant adenovirus vectorsFERRING INT CENTER SA·Filed 2025·Application pending·0 cites
- 1353US2025388873A1Method for the purification of recombinant adenovirus vectorsFERRING INT CENTER SA·Filed 2025·Application pending·0 cites
- 1429US12263246B2Manufacturing of pharmaceutical compositionsFERRING INT CENTER SA·Filed 2018·Granted Apr 1, 2025·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →